Medicines Classification




NEW ZEALAND GAZETTE

No. 161

Quinine; and its salts; in medicines containing 200 mg or less per dose form and in packs containing not more than 5 days’ supply for the treatment of cramp

Reproterol; and its salts; except in medicines for inhalation or for parenteral use

Rimiterol hydrobromide; except in medicines for inhalation or for parenteral use

Salbutamol; and its salts; except in medicines for inhalation or for parenteral use

Solanaceous alkaloids; and their salts; in medicines not specified elsewhere in this notice; and in medicines containing 0.15% and less of solanaceous alkaloids calculated as hyoscyamine; except in forms for parenteral use

Sulphacetamide; and its salts; in ophthalmological medicines

Terbutaline; and its salts; except in medicines for inhalation or for parenteral use

Tioconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Triamcinolone acetonide; in medicines for buccal use and when in a pack containing 5 mg or less of triamcinolone acetonide

Tulobuterol; and its salts; except in medicines for inhalation or for parenteral use.

Third Schedule

Pharmacy-Only Medicines

Amethocaine; and its salts; in medicines for external use except in medicines for ophthalmological use

Aminophylline; in liquid form for oral use

Benzydamine; and its salts

Benzoyl peroxide; in medicines for external use containing more than 5% of benzoyl peroxide

Benzyl benzoate; in medicines containing more than 2.5% of benzyl benzoate

Biphenylacetic acid

Bisacodyl

Bithionol

Bufexamac

Calcium glucono-galacto-gluconate; for parenteral use

Carboxymethylcysteine

Cetirizine; and its salts

Chlophedianol hydrochloride

Ciclopirox; for dermatological use in medicines containing 1% or less of ciclopirox

Clidinium; and its salts

Desoxyribonuclease; for external use

Dextranomer

Dextromethorphan; and its salts; in medicines containing more than 0.25% of dextromethorphan

Diclofenac; and its salts; in medicines for external use but not ophthalmological use

Dicyclomine; and its salts

Dimenhydrinate; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Emetine; and its salts; except in ipecacuanha and tinctures of ipecacuanha, and in medicines containing more than 0.05% of emetine

Ether; when used as a vehicle for a topical dose form

Fluorescein

Fluorides; in medicines for internal use containing 2.2 milligrams or less of fluoride per dosage unit; in medicines for external use containing fluoride in proportion equivalent to more than 0.1% of elemental fluorine

Folic acid; in medicines containing more than 500 mcg of folic acid per recommended daily dose

Glucagon

Guaiphenesin; in medicines containing more than 2% of guaiphenesin

Hydrocortisone; and hydrocortisone acetate; in medicines for dermatological use containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container

Hydroquinone; in medicines containing more than 2% of hydroquinone

Idoxuridine; in medicines containing 0.5% or less of idoxuridine for dermatological use

Indomethacin; in medicines for external use containing 1% or less of indomethacin

Ipecacuanha

Jaborandi; alkaloids of; and its salts; in medicines containing 0.5% or more of the alkaloids of jaborandi

Ketoconazole; for dermatological use

Ketoprofen; and its salts; in medicines for external use

Lignocaine; and its salts; in medicines for external use containing more than 2% of lignocaine

Lobelia; alkaloids of; and its salts

Loratadine

Meclozine; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Mefenamic acid; and its salts; in solid dose forms of 250 mg or less and in a pack containing not more than 20 tablets or capsules with the treatment of dysmenorrhoea

Mequitazine

Naproxen; and its salts; in solid dose forms containing the equivalent of 250 mg or less of naproxen per dose form, when in a pack containing not more than 20 tablets or capsules and sold for the treatment of dysmenorrhoea

Nicotine; in medicines for transdermal use

Noradrenaline; and its salts

Nystatin; in medicines for dermatological use

Oxerutins

Oxiconazole nitrate

Oxymetazoline; and its salts; for nasal use except when sold at an airport

Paracetamol; except where specified elsewhere in this notice

Phenazone

Phenylephrine; for nasal use except when sold at an airport

Piroxicam; in medicines for external use containing 1% or less of piroxicam

Polygeline

Potassium chloride; except in medicines for oral rehydration therapy

Potassium perchlorate

Promethazine; and its salts; except promethazine theoclate in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1993, No 161


NZLII PDF NZ Gazette 1993, No 161





✨ LLM interpretation of page content

🏥 Classification of Medicines under the Medicines Act 1981 (continued from previous page)

🏥 Health & Social Welfare
27 October 1993
Medicines Act, Classification of Medicines, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, General Sale Medicines